We for you in
go to: LeitnerLeitner
News > Deal Alert: Topcon Healthcare has acquired Vienna based RetInSight

Deal Alert: Topcon Healthcare has acquired Vienna based RetInSight

– 15.05.2025

Deal Alert Website Topcon Healthcare

Topcon Healthcare has acquired Vienna based RetInSight, strengthening its global leadership in AI powered imaging for ophthalmology. We would like to congratulate the team at Topcon on this outstanding achievement!

RetInSight develops AI driven solutions for the early detection and monitoring of retinal diseases – such as geographic atrophy, age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Their technology enables personalized treatment approaches and improves patient care worldwide. We at LeitnerLeitner are proud to have advised Topcon Healthcare on this strategic acquisition and are delighted to see the transaction successfully closed.

LeitnerLeitner Deal Team:
 Christian Oberhumer, Michael Pucher, Frank Schiefersteiner, Thomas Pfeifenberger with support from Michael Kueschnig and Stefan Lindner.

authors

Print article share article

further

Events — 08.04.2025
Good Morning CEE - Practical lessons learned from recent tax audits and court cases in CEE
Newsletter — 12.02.2025
VAT Newsletter fourth quarter 2024
Newsletter — 04.11.2024
VAT Newsletter third quarter 2024
Events — 07.11.2024
International VAT Expert Academy 2024
Events — 27.08.2024
Wealth Structuring Solutions for Central and Eastern Europe
Newsletter — 26.07.2024
VAT Newsletter - second quarter 2024
Events — 24.05.2024
VAT Neutrality across Europe: strategies and insights

This website uses cookies and other technologies to provide you with the best possible online experience and to compile anonymous usage statistics. If you allow these cookies, you consent to the processing of your data collected via these cookies also, as the case may be, in the USA (Art 49(1)(a) DSGVO). Please note that according to recent decisions by the Office for the Protection of Personal Data and the case law of the Court of Justice of the European Union, the United States does not ensure an adequate level of data protection (see Case C-311/18, Schrems II). In particular, access by US authorities (FISA 0702) is not comprehensively restricted by law, does not require approval by an independent authority and there are no relevant legal remedies against such access available. As the user, you determine which data and information we may process. By selecting “allow all cookies” you accept all types of cookies. You can select and confirm your personal preference using the “necessary cookies” or “functional cookies” buttons. For additional information, please see our Privacy Notice.